Phys Written Answers · neurological
Peripheral Neuropathy — Written Clinical Reasoning
DCE long-case preparation: structured written reasoning for peripheral neuropathy — the four classification axes (fibre type, distribution, time course, axonal versus demyelinating), the approach to a diagnostic challenge combining diabetic distal symmetric polyneuropathy with a superimposed vasculitic mononeuritis multiplex, the investigation pathway (NCS/EMG, blood panels, CSF, genetics, biopsy), and the three-pillar management (treat the cause, neuropathic pain, foot care and falls prevention).
On this page
Study tools
Target exams
Peripheral Neuropathy — Written Clinical Reasoning
Part A — Diagnostic approach and classification
The first discipline is to classify the neuropathy before generating a differential. This patient has two superimposed patterns — a chronic distal symmetric polyneuropathy (the 3-year burning numbness, stocking-distribution sensory loss, absent ankle reflexes, and painless foot ulcer) and a subacute mononeuritis multiplex (the 6-week history of painful, asymmetric, stepwise involvement of the right peroneal nerve and the right ulnar nerve, with weight loss and night sweats). [1]
The chronic distal symmetric pattern is, by far, most likely diabetic distal symmetric polyneuropathy (DSPN) in a man with a 15-year history of type 2 diabetes and an HbA1c of 78 mmol per mol — the poor glycaemic control, the length-dependent sensory loss, the absent ankle reflexes, and the painless foot ulcer (the classic triad of neuropathy, ischaemia, and deformity) are all consistent [1].
The superimposed subacute mononeuritis multiplex is the concerning new development. Mononeuritis multiplex — painful, asymmetric, stepwise involvement of multiple individual named nerves — is the signature of vasculitic neuropathy until proven otherwise [4], and the systemic symptoms of weight loss and night sweats raise the possibility of an underlying systemic vasculitis or a paraproteinaemic process. The small IgM kappa paraprotein adds a further layer — it may be an incidental MGUS, or it may be relevant (anti-MAG neuropathy is typically a chronic distal demyelinating sensory neuropathy, not a mononeuritis multiplex, but paraproteinaemic disease and vasculitis can coexist, and cryoglobulinaemic vasculitis is classically associated with a paraprotein and hepatitis C).
Key point: Never assume that all neuropathy in a diabetic patient is due to diabetes. Up to 10 to 50 per cent of neuropathy in diabetics has an alternative or additional cause. The new, subacute, asymmetric, painful, stepwise pattern in this patient demands investigation for vasculitis and paraproteinaemic disease. [1]
References5ShowHide
- [1]Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments Diabetes Care, 2010.PMID 20876709
- [2]England JD, Gronseth GS, Franklin G, et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation Neurology, 2009.PMID 19056666
- [3]Willison HJ, Jacobs BC, van Doorn PA Guillain-Barré syndrome Lancet, 2016.PMID 26948435
- [4]Heestermans AA, van Werkum JW, Zwart B, et al. Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome J Thromb Haemost, 2010.PMID 20831622
- [5]Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision Eur J Neurol, 2010.PMID 20402746